Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine

V. Nerandzic, P. Mrozkova, P. Adamek, D. Spicarova, I. Nagy, J. Palecek,

. 2018 ; 175 (12) : 2322-2336. [pub] 20170611

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 1968 to 1 year ago
PubMed Central from 1968 to 2020
Europe PubMed Central from 1968 to 1 year ago
Medline Complete (EBSCOhost) from 2002-01-01 to 1 year ago
Wiley Free Content from 1997 to 1 year ago

BACKGROUND AND PURPOSE: Endocannabinoids play an important role in modulating spinal nociceptive signalling, crucial for the development of pain. The cannabinoid CB1 receptor and the TRPV1 cation channel are both activated by the endocannabinoid anandamide, a product of biosynthesis from the endogenous lipid precursor N-arachidonoylphosphatidylethanolamine (20:4-NAPE). Here, we report CB1 receptor- and TRPV1-mediated effects of 20:4-NAPE on spinal synaptic transmission in control and inflammatory conditions. EXPERIMENTAL APPROACH: Spontaneous (sEPSCs) and dorsal root stimulation-evoked (eEPSCs) excitatory postsynaptic currents from superficial dorsal horn neurons in rat spinal cord slices were assessed. Peripheral inflammation was induced by carrageenan. Anandamide concentration was assessed by mass spectrometry. KEY RESULTS: Application of 20:4-NAPE increased anandamide concentration in vitro. 20:4-NAPE (20 μM) decreased sEPSCs frequency and eEPSCs amplitude in control and inflammatory conditions. The inhibitory effect of 20:4-NAPE was sensitive to CB1 receptor antagonist PF514273 (0.2 μM) in both conditions, but to the TRPV1 antagonist SB366791 (10 μM) only after inflammation. After inflammation, 20:4-NAPE increased sEPSCs frequency in the presence of PF514273 and this increase was blocked by SB366791. CONCLUSIONS AND IMPLICATIONS: While 20:4-NAPE treatment inhibited the excitatory synaptic transmission in both naive and inflammatory conditions, peripheral inflammation altered the underlying mechanisms. Our data indicate that 20:4-NAPE application induced mainly CB1 receptor-mediated inhibitory effects in naive animals while TRPV1-mediated mechanisms were also involved after inflammation. Increasing anandamide levels for analgesic purposes by applying substrate for its local synthesis may be more effective than systemic anandamide application or inhibition of its degradation. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035610
003      
CZ-PrNML
005      
20191010111613.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bph.13849 $2 doi
035    __
$a (PubMed)28476070
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Nerandzic, Vladimir $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
245    10
$a Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine / $c V. Nerandzic, P. Mrozkova, P. Adamek, D. Spicarova, I. Nagy, J. Palecek,
520    9_
$a BACKGROUND AND PURPOSE: Endocannabinoids play an important role in modulating spinal nociceptive signalling, crucial for the development of pain. The cannabinoid CB1 receptor and the TRPV1 cation channel are both activated by the endocannabinoid anandamide, a product of biosynthesis from the endogenous lipid precursor N-arachidonoylphosphatidylethanolamine (20:4-NAPE). Here, we report CB1 receptor- and TRPV1-mediated effects of 20:4-NAPE on spinal synaptic transmission in control and inflammatory conditions. EXPERIMENTAL APPROACH: Spontaneous (sEPSCs) and dorsal root stimulation-evoked (eEPSCs) excitatory postsynaptic currents from superficial dorsal horn neurons in rat spinal cord slices were assessed. Peripheral inflammation was induced by carrageenan. Anandamide concentration was assessed by mass spectrometry. KEY RESULTS: Application of 20:4-NAPE increased anandamide concentration in vitro. 20:4-NAPE (20 μM) decreased sEPSCs frequency and eEPSCs amplitude in control and inflammatory conditions. The inhibitory effect of 20:4-NAPE was sensitive to CB1 receptor antagonist PF514273 (0.2 μM) in both conditions, but to the TRPV1 antagonist SB366791 (10 μM) only after inflammation. After inflammation, 20:4-NAPE increased sEPSCs frequency in the presence of PF514273 and this increase was blocked by SB366791. CONCLUSIONS AND IMPLICATIONS: While 20:4-NAPE treatment inhibited the excitatory synaptic transmission in both naive and inflammatory conditions, peripheral inflammation altered the underlying mechanisms. Our data indicate that 20:4-NAPE application induced mainly CB1 receptor-mediated inhibitory effects in naive animals while TRPV1-mediated mechanisms were also involved after inflammation. Increasing anandamide levels for analgesic purposes by applying substrate for its local synthesis may be more effective than systemic anandamide application or inhibition of its degradation. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
650    _2
$a zvířata $7 D000818
650    _2
$a karagenan $7 D002351
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a zánět $x chemicky indukované $x metabolismus $7 D007249
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a fosfatidylethanolaminy $x chemická syntéza $x chemie $x farmakologie $7 D010714
650    _2
$a buňky zadních rohů míšních $x účinky léků $x metabolismus $7 D020671
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a mícha $x účinky léků $x metabolismus $7 D013116
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a nervový přenos $x účinky léků $7 D009435
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mrozkova, Petra $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Adamek, Pavel $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic.
700    1_
$a Spicarova, Diana $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Nagy, Istvan $u Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer Imperial College London, Faculty of Medicine, Chelsea and Westminster Hospital, London, UK.
700    1_
$a Palecek, Jiri $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
773    0_
$w MED00009383 $t British journal of pharmacology $x 1476-5381 $g Roč. 175, č. 12 (2018), s. 2322-2336
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28476070 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191010112032 $b ABA008
999    __
$a ok $b bmc $g 1452270 $s 1074160
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 175 $c 12 $d 2322-2336 $e 20170611 $i 1476-5381 $m British journal of pharmacology $n Br J Pharmacol $x MED00009383
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...